An increasing number of experimental chemotherapeutic agents induce apoptosis by directly triggering mitochondrial membrane permeabilization (MMP). Here we examined MMP induced by lonidamine, arsenite, and the retinoid derivative CD437. Cells overexpressing the cytomegalovirus-encoded protein vMIA, a protein which interacts with the adenine nucleotide translocator, were strongly protected against the MMP-inducing and apoptogenic eects of lonidamine, arsenite, and CD437. In a cell-free system, lonidamine, arsenite, and CD437 induced the permeabilization of ANT proteoliposomes, yet had no eect on protein-free liposomes. The ANTdependent membrane permeabilization was inhibited by the two ANT ligands ATP and ADP, as well as by recombinant Bcl-2 protein. Lonidamine, arsenite, and CD437, added to synthetic planar lipid bilayers containing ANT, elicited ANT channel activities with clearly distinct conductance levels of 20+7, 100+30, and 47+7 pS, respectively. Altering the ATP/ADP gradient built up on the inner mitochondrial membrane by inhibition of glycolysis and/or oxidative phosphorylation dierentially modulated the cytocidal potential of lonidamine, arsenite, and CD437. Inhibition of F 0 F 1 ATPase without glycolysis inhibition sensitized to lonidamine-induced cell death. In contrast, only the combined inhibition of glycolysis plus F 0 F 1 ATPase sensitized to arsenite-induced cell death. No sensitization to cell death induction by CD437 was achieved by glucose depletion and/or oligomycin addition. These results indicate that ANT is a target of lonidamine, arsenite, and CD437 and unravel an unexpected heterogeneity in the mode of action of these three compounds. Oncogene (2001) 20, 7579 ± 7587.
Introduction
Mitochondrial membranes undergo major changes in their integrity and/or permeability early during the apoptotic process (Green and Kroemer, 1998; Green and Reed, 1998; Kroemer and Reed, 2000) . The outer mitochondrial membrane becomes permeable to intermembrane proteins up to 100 kDa, via a mechanism that may or may not involve, depending on the model of cell death, a local disruption of the lipid bilayer (Martinou and Green, 2001; Zamzami and Kroemer, 2001 ). The inner membrane manifests a partial (and sometimes transient) permeabilization to compounds up to 1500 Da. This mitochondrial membrane permeabilization (MMP) has been shown to constitute a rate limiting, critical event of the apoptotic process including in chemotherapy-induced apoptosis (Costantini et al., 2000b) . MMP is lethal for the cell, for at least two reasons. First, intermembrane proteins normally sequestered to mitochondria (in particular cytochrome c and apoptosis inducing factor, AIF) are liberated into the extramitochondrial compartment and activate caspases and nucleases (Ferri et al., 2000; Joza et al., 2001; Liu et al., 1996; Loeer et al., 2001; Susin et al., 1999) . Second, MMP causes a metabolic catastrophe due to the cessation of ATP generation and/or the loss of the redox-balancing function of mitochondria (Hirsch et al., 1997; Kroemer et al., 1998) . MMP is regulated by anti-apoptotic members of the Bcl-2 family which stabilize the barrier function of mitochondrial membranes (Kroemer, 1997) . Most agents used in conventional chemotherapy have no direct eects on mitochondria. Rather, they elicit signal transduction pathways which aect mitochondria. Prominent examples include the p53-induced upregulation of proteins acting on mitochondria (e.g. the Bcl-2 antagonist Bax, p53-Apl, proline oxidase etc.) (Vogelstein et al., 2000) , as well as the generation of small second messengers including Ca 2+ , ganglioside GD3 (Rippo et al., 2000) , reactive oxygen species (ROS) (Costantini et al., 2000a) , nitric oxide and peroxynitrite . During the last 3 years it has been discovered that a number of experimental chemotherapeutic agents directly aect mitochondria. This applies to betulinic acid (Fulda et al., 1998a,b) , PK11195 (Hirsch et al., 1998) , diamide (Costantini et al., 2000a; Zamzami et al., 1998) , lonidamine (LND) (Ravagnan et al., 1999) , arsenite (Ars) (Larochette et Figure 1 vMIA-mediated inhibition of apoptosis induced by LND, Ars, and CD437. (a) HeLa cells transfected with the vector only (Neo) or vMia were cultured for 10 h in the absence (Co.) or presence of 600 mM LND, 30 mM Ars, or 24 mM CD437, followed by staining with the DC m -sensitive dye DiOC 6 (3), as well as the ROS-sensitive¯uorogenic compound HE. Representative pictograms obtained by cyto¯uorometric analysis of 10 000 cells are shown. Numbers refer to the percentage of cells found in each quadrant. (b) Cells cultured for 20 h as in a were ®xed and permeabilized with ethanol, followed by staining with propidium iodide (PI) and determination of the DNA content by¯ow cytometry. Numbers refer to the percentage of cells with a subdiploid DNA content. Results are representative of three independent experiments al., 1999), 6[3-adamantyl-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) (Marchetti et al., 1999) , 2-chloro-2'deoxyadenosine, 2-chloro-2'-ara¯uorodeoxy-adenosine (Genini et al., 2000) , MT-21 (Watabe et al., 2000) , vertepor®n , resveratrol (Tinhofer et al., 2001) , and perhaps even paclitaxel (Andre et al., 2000) .
The exact molecular mechanisms accounting for MMP are a matter of debate and may well dier, depending on the apoptosis-inducing trigger. According to some authors, pro-apoptotic members of the Bcl-2/Bax family insert in the outer mitochondrial membrane where they oligomerize and form proteinpermeable conduits in an autonomous fashion that does not involve any interactions with sessile mitochondrial proteins (Martinou and Green, 2001; Saito et al., 2000) . Another model predicts that the voltagedependent anion channel (VDAC) of the outer membrane interacts with Bax-like proteins to form a non-speci®c pore (Shimizu et al., 2000) . Yet another model, initially proposed by our group, predicts that the adenine nucleotide translocase (ANT) in the inner membrane can form a channel which, upon opening, triggers matrix swelling and physical disruption of the outer membrane Costantini et al., 2000b; Jacotot et al., 2001; Marzo et al., 1998) . ANT reconstituted into arti®cial membranes, either liposomes or planar lipid bilayers, has indeed been shown to form non-speci®c, cation-selective ion channels with a maximum conductance of 600 pS , depending on the MMP-inducing agent added into the experimental system: Ca 2+ (70; 250; 300 ± 600 pS) Brustovetsky and Klingenberg, 1996) , atractyloside (Atr) (30 pS) , or viral protein R (Vpr) encoded by HIV-1 (190 pS) . Cooperative channel formation has been found for ANT and Bax Jacotot et al., 2001; Marzo et al., 1998) , leading to the formation of channels with a higher opening probability and a larger conductance. Conversely, Bcl-2 inhibits channel formation by ANT Jacotot et al., 2001) . Altogether these results suggest that ANT can ful®ll two distinct functions. First, ANT is responsible for the stoichiometric exchange of ATP and ADP across the inner mitochondrial membrane. In addition, ANT seems to be a potentially lethal pore-forming protein. These two functions may be somehow intertwined since ATP and ADP, the two physiological ANT ligands, strongly in¯uence pore formation by puri®ed ANT in vitro Jacotot et al., 2001) , MMP studied on puri®ed mitochondria (Zoratti and SzaboÁ , 1995) , as well as the susceptibility of cells to undergo cell death in response to chemotherapeutic agents (Leist et al., 1997; Martin et al., 2001) .
Based on the above mentioned premises, we decided to investigate the mechanisms of MMP induced by three experimental anti-cancer agents, namely LND, Ars, and CD437. Here, we report that all three agents may favor MMP via a direct eect on ANT. Our data reveal unexpected dierences in the mode of action of these three molecules that lead to ANT-dependent membrane permeabilization.
Results and Discussion
The ANT-targeted protein vMIA inhibits apoptosis induced by LND, Ars, and CD437
The cytomegalovirus-encoded protein UL37, also called vMIA (for viral mitochondrial inhibitor of apoptosis), is predominantly localized in mitochondria (Colberg-Poley et al., 2000; Goldmacher et al., 1999) , where it selectively interacts with ANT (Goldmacher et al., 1999) . HeLa cells stably transfected with a control vector only (Neo) or vMIA were exposed to LND, Ars, and CD437 at their respective LD 50 (determined for untransfected HeLa cells, not shown), followed by examination of three apoptosis-related parameters: (i) the dissipation of the DC m (measured with the potential-sensitive dye 3,3'dihexyloxacarbocyanine iodide [DiOC 6 (3)]), (ii) the mitochondrial generation of ROS (measured by assessing the oxidation of hydroethidine (HE) into ethidium), and (iii) the loss of nuclear DNA content (determined by a¯ow-cytometric analysis of cells staining with propidium iodide (PI)). As shown in Figure 1 , vMIA provides a strong protection against the DC m loss (Figure 1a ), ROS generation ( Figure 1a ), and DNA degradation ( Figure  1b ) induced by LND, Ars, and CD437 cells. Similar results were obtained with BJAB cells stably transfected with Neo or vMIA that were exposed to LND, Ars, CD437 (not shown). Altogether, these results suggest that an ANT-mediated process constitutes a rate-limiting event in cell death induced by LND, Ars, and CD437.
ANT facilitates membrane permeabilization induced by LND, Ars, and CD437
To examine if ANT is a direct target of LND, Ars, and CD437, we performed the following experiment. Liposomes containing phosphatidylcholine and cardiolipin (the two principal lipids of the inner mitochondrial membrane) with entrapped 4-methylumbelliferylphosphate (4-MUP) were made with either reconstituted ANT, or without any protein added (plain liposomes). These liposomes were exposed to increasing doses of Atr, LND, Ars, and CD437 and the release of 4-MUP was detected by addition of alkaline phosphatase, leading to its conversion to the¯uor-ochrome 4-methylumbelliferone (4-MU) (Figure 2a ). Liposomes containing puri®ed ANT protein were readily permeabilized by LND, Ars, and CD437, in a dose-dependent fashion while plain liposomes remained intact (Figure 2a) . We then examined the eects of ATP, ADP and Bcl-2 on the permeabilizing activities of these agents. ATP and ADP are natural ligands of ANT. Bcl-2 has been reported to interact with ANT and to inhibit ANT-mediated pore formation Jacotot et al., 2001) . All the three molecules, ATP, ADP, and Bcl-2 strongly inhibited the permeabilization of ANT liposomes induced by LND, Ars, and CD437 (Figure 2b ). When ANT liposomes were preloaded with ATP, exogenous ADP causes the (ANT-dependent) release of ATP, detectable by a luciferase chemiluminescence assay (Figure 3a) . This ATP/ADP translocase activity was inhibited by the thiol crosslinking agent, diazenedicarboxylic acid bis 5N, N-dimethylamide (diamide) (Figure 3b) , which causes the oxydation of a critical cysteine residue (Cys 56) of ANT and alters its conformation (Costantini et al., 2000a) . In contrast, none of the three experimental anti-cancer agents inhibited the translocase activity of ANT (Figure 3c ) at a concentration inducing ANT-dependent membrane permeabilization. In conclusion, LND, Ars, and CD437 speci®cally induce the pore-forming activity of ANT, yet do not aect its translocase function.
Distinct ANT-dependent channel activities elicited by LND, Ars, and CD437
ANT reconstituted into planar lipid bilayers, on its own, does not form any ion channels, as determined by Brustovetsky and Klingenberg, 1996; Jacotot et al., 2001; Vieira et al., 2000; Zamzami et al., 2000) , unless apoptogenic agents such as Ca 2+ Brustovetsky and Klingenberg, 1996) , atractyloside Zamzami et al., 2000) or Vpr ) are added. We therefore evaluated the eect of LND, Ars, and CD437 on the channelforming activity of ANT reconstituted into planar lipid bilayers. We found (Figure 4 ) that these three agents stimulated the generation of channels by ANT, yet had no eect on ANT-free lipid bilayers (not shown). This result was in agreement with the liposome permeabilization assays (Figure 2) . Surprisingly, LND, Ars, and CD437 yielded qualitatively dierent ion channel activities, with conductance values of 20+7, 100+30, and 47+7 pS, respectively. This result suggests that LND, Ars, and CD437 have subtle conformational eects on ANT (or on the ANT/lipid interphase) that depend on the exact physicochemical properties of each agent.
Distinct cellular activities of LND, Ars, and CD437
We examined the cytotoxic potential of LND, Ars, and CD437 on cells pre-treated with oligomycin or starved in a glucose-de®cient medium. These treatments alter the ATP/ADP gradient built up on the inner mitochondrial membrane (Leist et al., 1997) . Jurkat T lymphoma cells stably transfected with Bcl-2 or vector only (Neo) were cultured in conditions that allow for glycolytic and/or respiratory ATP generation (that is in the presence or absence of glucose and/or the F 0 F 1 ATPase inhibitor oligomycin), followed by the determination of DC m and ROS production as parameters of cell death ( Figure 5 ). Inhibition of F 0 F 1 ATPase without inhibition of glycolysis sensitized the cells to LND-induced cell death (Figure 5c ). In contrast, only the combined inhibition of glycolysis plus F 0 F 1 ATPase sensitized to Ars-induced cell death (Figure 5e) . No sensitization to cell death induction by CD437 was achieved by glucose depletion and/or oligomycin addition (Figure 5g ). In addition, inhibition of glycolytic ATP generation did not signi®cantly aect the pro-apoptotic eect of the three chemotherapeutic agents. Of note, similar results were obtained both in Neo and Bcl-2-overexpressing cells. Interestingly, under conditions of ATP depletion in the mitochondrial matrix (addition of oligomycin), Bcl-2 failed to protect against the cytocidal eect of LND (Figure 5d ). Moreover, only when ATP was depleted both from the cytoplasm and the matrix, Bcl-2 lost its capacity to protect the cells from Ars-induced apoptosis ( Figure  5f ). When ATP production was uninhibited, Bcl-2 reduced apoptosis induced by LND and Ars. However, Bcl-2 failed to protect from CD437-induced apoptosis, at least in Jurkat cells, in base line conditions ( Figure  5h ), in contrast to what has been reported for Rat-1 cells (Marchetti et al., 1999) . Only when glyclolysis was inhibited, Bcl-2 appeared to reduce the CD437 eect (Figure 5h ). We have no explanation for these cell-type-speci®c Bcl-2 eect. In any case, these results suggest that LND, Ars, and CD437 dier in their death-inducing mode of action.
Concluding remarks
Based on the results reported in this work, LND, Ars, and CD437 can be considered as agents which induce MMP via a direct eect on ANT. This interpretation is based on our observations that ANT-targeted vMIA strongly reduces LND-, Ars-, and CD437-induced cell death (Figure 1) , and that ANT-containing liposomal membranes (Figure 2 ) or synthetic planar lipid bilayers (Figure 4 ) are sensitive to the membrane-permeabilizing eect of LND, Ars, and CD437. ANT-mediated sensitization to LND-, Ars-, and CD437-triggered permeabilization is blocked by the ligands of ANT, ATP and ADP, (Figure 2 ) and by Bcl-2, a protein that directly interacts with the`apoptogenic domain' of ANT Marzo et al., 1998; . These results extend and con®rm our previous observation that, when added to intact cells or puri®ed mitochondria, LND, Ars, and CD437 induced MMP in a reaction that was inhibited by the apoptosis-inhibitory ANT ligand bongkrekic acid, as well as by cyclosporin A (which acts on the ANTinteracting protein cyclophilin D) (Bauer et al., 1999; Larochette et al., 1999; Marchetti et al., 1999; Ravagnan et al., 1999) . As a result, ANT is (one of) the rate-limiting target(s) of the apoptogenic eects of LND, Ars, and CD437.
Based on our data, it would be an oversimpli®cation, however, to assume that LND, Ars, and CD437 induce MMP via exactly the same ®ne mechanism. Although all three agents have a similar eect on proteoliposomes, namely ANT-dependent membrane, Bcl-2 and ADP/ATP-inhibitable permeabilization (Figure 2) , close examination of the ion channel activity elicited in ANT-containing lipid bilayers reveals that LND, Ars, and CD437 induced the formation of channels with signi®cantly dierent electrophysiological properties (Figure 4) . This expands the observation on heterogeneous channel properties elicited by Ca 2+ , Atr, and Vpr mentioned in the Introduction, while evoking an intriguing conundrum. How is it possible that the same protein, ANT, can respond by forming a large range of distinct channel activities, the exact conductance of which is determined by the agent acting on ANT or on the ANT/lipid interphase? As a possibility, rather than forcing ANT into one of its two principal conformations (the`c' and the`m' states according to Klingenberg's¯ip-¯op model of the ANT, viewed as an antiporter, Klingenberg, 1980) , ANTtropic agents may interact with a yet-to-be de®ned binding site, thereby forcing the ANT into an intermediate conformation, the pore-forming lumen of which would depend on the physicochemical properties of the ligand. Irrespective of this theoretical consideration, a second line of evidence suggests that LND, Ars, and CD437 trigger cell death via slightly divergent mechanisms. Inhibition of glycolytic and/or mitochondrial ATP generation, which may be expected to in¯uence the ADP/ATP gradient built up on the inner mitochondrial membrane, dierentially aected the LND-, Ars-, and CD437-mediated cytotoxicity ( Figure 5 ). Although alternative explanations are possible, it is tempting to speculate that the modulation of local ADP/ATP gradients impinges on ANT conformation or oligomerization, thereby facilitating (or not) the LND-, Ars-, and CD437-induced MMP. In any case, it appears that inhibition of oxidative phosphorylation (the case of LND) or combined inhibition of glycolysis and oxidative phosphorylation (the case of Ars) strongly enhances cytotoxic eects and may potentiate the therapeutic ecacy of LND or Ars, even in Bcl-2 overexpressing cells.
Although, many dierent cell types are killed by LND, Ars, and CD437 in vitro, pre-clinical and clinical data suggest that these agents act with an acceptable degree of selectivity on certain tumor cells in vivo. For instance, arsenite has become the therapeutic agent of choice for the treatment of acute myelomonocytic leukemia (Kroemer and de TheÂ , 1999; Soignet et al., 1998) . Whether this therapeutic selectivity may be attributed to the particular metabolic state of tumor cells and/or the status of the ANT (and ANTinteracting proteins) remains an open ®eld for future investigation.
Materials and methods

Chemicals and recombinant protein
When not speci®ed, chemicals were purchased from SIGMA. Recombinant Bcl-2 was a kind gift from JC Reed. The Burnham Institute, La Jolla, CA, USA .
Cell lines, and cytofluorimetric analysis of apoptosis
Jurkat cells (J-Neo) or Jurkat cells constitutively overexpressing Bcl-2 (J-Bcl-2) (Aillet et al., 1998) , kindly provided by N Israel (Pasteur Institute, Paris, France), HeLa cells stably transfected with the cytomegalovirus UL37 exon 1 gene coding for vMIA (H-vMIA) (Goldmacher et al., 1999) , as well as control cells transfected with the pcDNA3 vector containing the neomycin resistance gene (H-Neo) were cultured in RPMI-1640 (Jurkat) or DMEM (HeLa) medium supplemented with 10% heat inactivated-FCS and antibiotics at 378C under 5% CO 2 . Jurkat cells were washed and resuspended in RPMI 1640 medium without glucose containing 2 mM pyruvate. After adaptation to this medium, cells were exposed to 0 or 2.5 mM oligomycin for 45 min (Leist et al., 1997) . Then, 1 ± 5.10 5 cell/ml were treated with various doses of lonidamine (LND, Angelini Research Institute, Rome, Italy), arsenic trioxide (Ars) and the retinoid 6-[3-(1-adamantyl)-4-hydroxyphenil]-2-naphtalene carboxylic acid (CD437, CIRD Galderma, Sophia Antipolis, France). Cells were then labeled with 40 nM 3-3'-dihexyloxacarbocyanineiodide (DiOC(6) 3 ; Molecular Probes, Eugene, OR, USA) and 2 mM dihydroethidine (HE; Molecular Probes, Eugene, OR, USA) for 10 min at 378C and were analysed by cyto¯uori-metry (FACSVantage, Becton Dickinson) as previously described (Zamzami et al., 1995) . The frequency of subdiploid cells was determined by propidium iodide (PI. 5 mM) staining of ethanol-permeabilized cells (Nicoletti et al., 1991) .
ANT purification and reconstitution in liposomes
ANT was puri®ed from rat heart mitochondria as previously described . After mechanical shearing, mitochondria were suspended in 220 mM mannitol, 70 mM sucrose, 10 mM HEPES, 200 mM EDTA, 10 mM dithiothreitol (DTT), 0.5 mg/ml subtilisin, pH 7.4, kept 8 min on ice and sedimented twice by dierential centrifugations (5 min, 500 g, and 10 min, 10 000 g). Mitochondrial proteins were solubilized by 6% [v:v] Triton X-100 (Boehringer Mannheim, Mannheim, Germany) in 40 mM K 2 HPO 4 , 40 mM KCl, 2 mM EDTA, pH 6.0, for 6 min at RT and solubilized proteins were recovered by ultracentrifugation (30 min, 24 000 g, 48C). Then, 2 ml of this Triton X-100 extract was applied to a column ®lled with 1 g of hydroxyapatite (BioGel HTP, BioRad), eluted with the before mentioned buer and diluted [v:v] with 20 mM MES, 200 mM EDTA, 0.5% Triton X-100, pH 6.0. The resulting sample was separated on a Hitrap SP column using a FPLC system (Pharmacia) and a linear NaCl gradient (0 ± 1 M). Puri®ed ANT and/or recombinant Bcl-2 were reconstituted in phosphatidylcholine (PC)/cardiolipin liposomes. Brie¯y, to prepare liposomes, 90 mg PC and 2 mg cardiolipin were mixed in 1 ml chloroform, and the solvent was evaporated under nitrogen. Dry lipids were then resuspended in 1 ml liposomes buer containing 0.3% n-octyl-b-D-glucopyranoside and mixed by continuous vortexing for 40 min at RT. ANT (0.1 mg/ml) and/or recombinant Bcl-2 (0.1 mg/ml) were then mixed with liposomes [v:v] and incubated for 20 min at RT. Proteoliposomes were dialysed overnight at 48C to remove detergent.
ADP/ATP translocase assay
ANT liposomes were sonicated in the presence of 5 mM ATP and 10 mM KCl (50 W, 22 s, Branson soni®er 250) on ice. Then, liposomes were separated on Sepadex G-25 columns (PD-10, Pharmacia) from unencapsulated products. Twenty®ve ml-aliquots liposomes were mixed with various concentrations of ADP, LND, Ars, or CD437 and incubated for 1 h at RT. Twenty-®ve ml luciferase (0.5 U/ml, Boehringer Mannheim) was added, and luminescence was determined by means of a Perkin Elmer spectrophotometer. Results are expressed as per cent of maximum translocase activity, as determined by addition of 800 mM ADP.
Pore opening assay
PTPC-or ANT-proteoliposomes were sonicated in the presence of 1 mM 4-MUP and 10 mM KCl (50 W, 22 s, Branson soni®er 250) on ice as previously described . Then, liposomes were separated on Sepadex G-25 columns (PD-10, Pharmacia) from unencapsulated products. Twenty-®ve ml-aliquots of liposomes were diluted to 3 ml in 10 mM HEPES, 125 mM saccharose, pH 7.4, mixed with the indicated concentrations of the pro-apoptotic inducers atractyloside, LND, Ars, or CD437 and incubated for 1 h at RT. Inhibitors of mitochondrial membranes permeabilization such as ATP and ADP, were added to the liposomes 30 min before chemotherapeutic agents treatment. After addition of 10 ml-alkaline phosphatase (5 U/ml, Boehringer Mannheim) diluted in liposomes buer +0.5 mM MgCl 2 , samples were incubated for 15 min at 378C under agitation and the enzymatic conversion of 4-MUP in 4-MU was stopped by addition of 150 ml of a buer containing 2 mM HEPES-NaOH and 200 mM EDTA (pH 10). The 4-MU-dependent¯uorescence was determined with a Perkin Elmer spectro¯uorimeter. Atractyloside (800 mM), a pro-apoptotic permeability transition inducer, was used in each experiment as an internal standard to determine the maximal (100%) response. The percentage of 4-MUP release induced by the three chemotherapeutic agents was calculated as follows: [(¯uorescence of treated liposomes ±¯uorescence of untreated liposomes)/(¯uorescence of liposomes treated by atractyloside ±¯uorescence of untreated liposomes)]6100.
Electrophysiological methods
Virtually solvent-free planar lipid bilayers were formed by the method of Montal and Mueller (1992) by the apposition of two monolayers on a 125 mm-é hole in a 10 mM Te¯on ®lm pre-treated with hexadecane/hexane (1 : 40, v:v) . Monolayers were generated using a lipid mixture of Palmitoyl-OleoyPhosphatidylCholine/DioleoylPhosphatidyl Ethanolamine (POPC/DOPE; 7 : 3; w:w) supplemented with 3% cardiolipin (Avanti, Birmingham, AL, USA) and dissolved in hexane (0.5%, w:v). The electrolyte solution was 0.1 M KCl, 10 mM N-2-hydroxyethylpiperazine-N'-2 ethanesulfonic acid (HEPES), 1 mM MgCl 2 (pH 7.4), in both compartments. Membrane currents under applied voltage were determined using a BLM 120 ampli®er (Biologic) and Ag/AgCl electrodes. The current¯uctuations were stored on a DTR 1202 (Biologic) and were analysed using software from Intracel. Conductance values were calculated as the ratio I/V. Abbreviations ANT, adenine nucleotide translocator; AIF, apoptosis inducing factor; Ars, arsenic trioxide; Atr, atractyloside; CD437, 6[3-adamantyl-4-hydroxyphenyl]-2-naphthalene carboxylic acid; Diamide, diazenedicarboxylic acid bis 5N, N-dimethylamide, DiOC 6 (3), 3,3'dihexyloxacarbocyanine iodide; DCm, mitochondral transmembrane potential; HE, hydroethidine; LND, lonidamine; MMP, mitochondrial membrane permeabilization; 4-MU; 4-methylumbelliferone; 4-MUP; 4-methylumbelliferylphosphate; PI, propidium iodide; ROS, reactive oxygen species; VDAC, voltage-dependent anion channel; vMIA, viral mitochondria-localized inhibitor of apoptosis; Vpr, viral protein R
